1 / 5

Albumin Market to Reach Valuation Worth US$1200 Mn by End of 2026

Albumin is a water soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries. However, usage of albumin as multifunctional excipient is increasing due to rise in consumption for applications such as drug formulation, vaccines, drug discovery, culture medium, stabilizing agent, and diagnostics. The global albumin (as excipient) market was valued at US$ 750 Mn in 2017 and is anticipated to reach US$ 1200 Mn by 2026 at a CAGR of over 5.0% from 2018 to 2026. Grant of regulatory approvals and trials coupled with subsequent launch of albumin-based products is expected to boost the growth of the market during the forecast period.

HealthcareInsights
Télécharger la présentation

Albumin Market to Reach Valuation Worth US$1200 Mn by End of 2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. ©2019 Transparency Market Research, All Rights Reserved Albumin is a water soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin Market ©2019 Transparency Market Research, All Rights Reserved

  2. ©2019 Transparency Market Research, All Rights Reserved Global Albumin (as Excipient) Market - Snapshots  Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries. However, usage of albumin as multifunctional excipient is increasing due to rise in consumption for applications such as drug formulation, vaccines, drug discovery, culture medium, stabilizing agent, and diagnostics.  The global albumin (as excipient) market was valued at US$ 750 Mn in 2017 and is anticipated to reach US$ 1200 Mn by 2026 at a CAGR of over 5.0% from 2018 to 2026. Grant of regulatory approvals and trials coupled with subsequent launch of albumin-based products is expected to boost the growth of the market during the forecast period.  The global albumin (as excipient) market has been segmented based on product, application, end-user, and region. In terms of product, the human serum albumin segment is anticipated to account for major market share of 80% in terms of revenue during the forecast period.

  3. ©2019 Transparency Market Research, All Rights Reserved Table of Content Sr. No. Content Chapter1 Preface Chapter 2 Assumptions and Research Methodology Chapter 3 Executive Summary: Global Albumin (as Excipient) Market Chapter 4 Market Overview Chapter 5 Market Outlook Global Albumin (as Excipient) Market Analysis and Forecast, by Product Type Chapter 6 Global Albumin (as Excipient) Market Analysis and Forecast, by Application Chapter 7 Global Albumin (as Excipient) Market Analysis and Forecast, by End- user Chapter 8

  4. ©2019 Transparency Market Research, All Rights Reserved Asia Pacific Region to Showcase Maximum Growth Potential Transparency Market Research has published a latest report that talks in detail about the global albumin market. According to the research report, the global albumin market is expected to reach a valuation worth US$1200 mn by the end of 2026. To achieve this valuation, the market is expected to grow at a rate of 5% CAGR over the course of the given forecast period of 2018 to 2026. The Asia Pacific region is expected to show maximum growth potential as compared to the other regional segments of North America, Latin America, Europe, and Middle East and Africa. The growth of the Asia Pacific region is high because of the growing demand for albumin in countries such as India and China. However, the rate of adoption is slightly lower due to lack of awareness and benefits of the product and its therapeutic benefits. Request Brochure of Report ©2019 Transparency Market Research, All Rights Reserved

  5. ©2019 Transparency Market Research, All Rights Reserved To know more about us, please visit our website: www.transparencymarketresearch.com For sales queries or new topics email us on: sales@transparencymarketresearch.com For other queries contact: 90 State Street, Albany NY – 12207, United States Tel: +1-518-618-1030 T H A N K Y O U

More Related